Baclofen Dosing Guidelines
Standard Adult Dosing
The FDA-approved starting dose for baclofen is 5 mg three times daily, with gradual titration every 3 days (5 mg TID → 10 mg TID → 15 mg TID → 20 mg TID), up to a maximum of 80 mg daily (20 mg four times daily). 1
Titration Schedule
- Days 1-3: 5 mg three times daily (15 mg/day total) 1
- Days 4-6: 10 mg three times daily (30 mg/day total) 1
- Days 7-9: 15 mg three times daily (45 mg/day total) 1
- Days 10-12: 20 mg three times daily (60 mg/day total) 1
- Beyond Day 12: Additional increases may be made, but do not exceed 80 mg/day 1
The optimal therapeutic dose typically falls between 40-80 mg daily, and the lowest effective dose should be used. 1
Elderly Patients
In elderly patients, start with the lowest possible dose (5 mg once or twice daily initially) and titrate more slowly than the standard schedule. 2
- Elderly stroke patients experience significantly higher rates of drowsiness and sedation with standard baclofen dosing 2
- Pharmacokinetic studies show elderly patients take longer to achieve peak plasma concentrations, though overall drug exposure (AUC) remains similar to younger adults 2
- The increased side effects in elderly patients appear related to age-related pharmacodynamic sensitivity rather than altered drug clearance 2
- Common pitfall: The FDA label's standard titration schedule is often too aggressive for elderly patients, leading to excessive sedation 3, 2
Renal Impairment
Baclofen should be dose-reduced in patients with moderate renal impairment (eGFR 30-60 mL/min/1.73m²) and avoided entirely in severe renal impairment (eGFR <30 mL/min/1.73m²) or dialysis patients. 4, 5
Specific Dose Adjustments by Renal Function
- Mild CKD (eGFR 50-80 mL/min): Reduce dose by approximately one-third 5
- Moderate CKD (eGFR 30-50 mL/min): Reduce dose by approximately one-half 5
- Severe CKD (eGFR <30 mL/min): Reduce dose by approximately two-thirds OR avoid use entirely 4, 5
- End-stage renal disease/dialysis: Avoid baclofen use due to high risk of neurotoxicity 4, 6
Critical Safety Considerations in Renal Impairment
Because baclofen is primarily renally excreted unchanged, it accumulates dangerously in kidney disease. 1, 4 Multiple case reports document severe neurotoxicity (encephalopathy, seizures, hemodynamic instability) in dialysis patients receiving even standard doses. 4, 6 Baclofen levels can rise gradually over time in patients with impaired renal clearance, even on stable dosing regimens. 7
Common pitfall: Serum creatinine may appear normal in elderly patients despite significant renal impairment due to reduced muscle mass; always calculate eGFR or creatinine clearance before prescribing. 8, 5
Pediatric Dosing
The FDA label does not provide specific pediatric dosing recommendations. 1 However, expert consensus for intrathecal baclofen in children suggests daily dose increases of 5-15% every 24 hours when titrating. 9 Oral baclofen dosing in children should follow similar conservative principles with lower starting doses and slower titration than adults.
Discontinuation
Never abruptly discontinue baclofen—taper slowly to avoid withdrawal seizures and hallucinations. 1
Abrupt withdrawal of baclofen can cause life-threatening complications including seizures, hallucinations, and autonomic instability. 1 When discontinuing, reduce the dose gradually over days to weeks depending on the total daily dose and duration of therapy.
High-Dose Considerations
While the FDA maximum is 80 mg/day 1, some patients with spasticity require higher doses for adequate symptom control. 7 High-dose baclofen (>80 mg/day) has been used safely in selected patients, but requires careful monitoring for:
- Prolonged time-to-peak levels and extended half-life at higher doses 7
- Gradual accumulation over time, particularly in patients with any degree of renal impairment 7
- Increased risk of CNS adverse effects (drowsiness, confusion, weakness) 3
If considering doses above 80 mg/day, ensure normal renal function and monitor closely for toxicity. 7
Key Adverse Effects to Monitor
Baclofen commonly causes fatigue, dizziness, somnolence/sedation, dry mouth, paresthesia, and muscle spasms/rigidity. 10 These effects are dose-dependent and particularly problematic in elderly patients. 3, 2 Start low and titrate slowly to minimize these side effects while achieving therapeutic benefit.